TAF9 and metabolic dysfunction-associated steatotic liver disease: Additionally, another study indicated that Danshensu protects against nonalcoholic fatty liver disease by significantly enhanced fatty acid β-oxidation and decreased lipid droplet accumulation in the histone deacetylase 1/TATA-box binding protein associated factor 9-dependent pathway 21.